MYX mayne pharma group limited

Ann: Wilsons investor conference presentation, page-6

  1. 15,004 Posts.
    lightbulb Created with Sketch. 1524
    Even when approved I think Nuvaring sales will be small.

    The main game is dermatology, Metric Contract Services and Nextstellis.

    Also Mithra is in late stage trials for a version of Nexstellis that helps women deal with menopause. That is a huge market and hopefully Mayne Pharma can partner with Mithra in the US and Australia given the relationship and 10% shareholding in MYX.

    Cheers.....D
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.05 $5.08 $5.02 $395.8K 78.38K

Buyers (Bids)

No. Vol. Price($)
1 1996 $5.05
 

Sellers (Offers)

Price($) Vol. No.
$5.08 3084 3
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.